视网膜病变和充血性心力衰竭的风险
Tien Y Wong1, Wayne Rosamond, Patricia P Chang
1Centre for Eye Research Australia, University of Melbourne, Victoria, Australia. ophwty@nus.edu.sg
JAMA
|January 6, 2005
概括
视网膜病变是微血管疾病的标志物,与充血性心力衰竭 (CHF) 的风险增加一倍有关. 这种关联甚至在没有先前心脏病,糖尿病或高血压的个体中仍然存在,这突显了微血管健康.
科学领域:
- 眼科医生 眼科 眼科
- 心脏病学 心脏病学
- 血管生物学 血管生物学
背景情况:
- 充血性心力衰竭 (CHF) 影响许多成年人,其起源不确定.
- 微血管疾病是潜在的,但尚未证实的,导致CHF病变的因素.
研究的目的:
- 调查视网膜病变之间的关联,一个全身微血管疾病指标,和发展心脏不全症的风险.
- 为了确定视网膜病变是否预测一般成年人群中CHF发病率.
主要方法:
- 这是一项为期7年的前性,基于人口的队列研究,涉及11612名年龄在49-73岁之间的参与者.
- 视网膜照片分析了视网膜病变和其他微血管症状.
- 事件CHF通过住院和死亡记录来确定.
主要成果:
- 患有视网膜病变的参与者表现出明显更高的CHF发病率 (15.1%对比4.8%).
- 视网膜病变在调整多种风险因素后,独立地与心血管衰竭风险增加2倍相关.
- 在没有先前存在冠心病,糖尿病或高血压的个体中,视网膜病变显示了心血管不全症的风险增加了3倍.
结论:
- 视网膜病变作为一种独立的CHF预测因子,独立于传统的风险因素.
- 研究结果表明,微血管疾病在心力衰竭的发展中起着重要作用.
- 视网膜病变的眼科查可以确定可能从进一步的心血管风险评估中受益的个人.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Heart Failure I: Introduction
2.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65
Diabetic Nephropathy
49
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
49


